Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy

Journal of Psychopharmacology

Volumn 22, Issue 7, 2008, Pages 778-783

  Shajahan, P ^a,c   MacRae, A ^b   Bashir, M ^a   Taylor, M ^b  

^a NHS LANARKSHIRE   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c Airbles Road Centre ^*  (United Kingdom)

Author keywords

Antipsychotics; Aripiprazole; Combination treatment

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AGITATION; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; LOW DRUG DOSE; MONOTHERAPY; NAUSEA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 50249182947     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107083483     Document Type: Article

References (20)

1. Barbee J.G., Conrad E.J., Jamhour N.J. (2004) Aripiprazole augmentation in treatment-resistant depression. Ann Clin Psychiatry 16 (4). 189-194
2. bnf.org (British National Formulary)
3. Casey D.E., Carson W.H., Saha A.R., Liebeskind A., Ali M.W., Jody D., Ingenito G.G. (2003) Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Aripiprazole Study Group. Psychopharmacology 166 (4). 391-399
4. Centorrino F., Fogarty K.V., Cimbolli P., Salvatore P., Thompson T.A., Sani G., Cincotta S.L., Baldessarini R.J. (2005) Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. J Psychiatr Practice 11 (4). 241-247
5. Christensen A.F., Poulsen J., Nielsen C.T., Bork B., Christensen A., Christensen M. (2006) Patients with schizophrenia treated with aripiprazole, a multi-centre naturalistic study. Acta Psychiatr Scand 113 (2). 148-153
6. Clark R.E., Bartels S.J., Mellman T.A., Peacock W.J. (2002) Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophrenia Bull 28 (1). 75-84
7. El-Sayeh H.G., Morganti C. (2007) EBM Reviews - Cochrane Database of Systematic Reviews Aripiprazole for schizophrenia. Cochrane Schizophrenia Group. Cochrane Database of Systematic Reviews. 1
8. Freudenreich O., Goff D.C. (2002) Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand 106 (5). 323-330
9. Guy W. (1976) ECDEU Assessment manual for psychopharmacology. US Department pf Health, Education, and Welfare. Rockville, MD: National Institute of Mental Health: 218-222
10. Kane J.M., Carson W.H., Saha A.R., McQuade R.D., Ingenito G.G., Zimbroff D.L., Ali M.W. (2002) Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 63 (9). 763-771
11. Kasper S., Lerman M.N., McQuade R.D., Saha A., Carson W.H., Ali M., Archibald D., Ingenito G., Marcus R., Pigott T. (2003) Efficacy and safety of aripiprazole vs haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. Neuropsychopharmacology 6: 325-337
12. Keck P.E. Jr, Marcus R., Tourkodimitris S., Ali M., Liebeskind A., Saha A., Ingenito G. (2003) Aripiprazole Study Group. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160 (9). 1651-1658
13. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B., Severe J., Hsiao J.K. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223
14. Pigott T.A., Carson W.H., Saha A.R., Torbeyns A.F., Stock E.G., Ingenito G.G. (2003) Aripiprazole Study Group. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. J Clin Psychiatry 64 (9). 1048-1056
15. Potkin S.G., Saha A.R., Kujawa M.J., Carson W.H., Ali M., Stock E., Stringfellow J., Ingenito G., Marder S.R. (2003) Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 60 (7). 681-690
16. Reeves R.R., Mack J.E. (2004) Worsening schizoaffective disorder with aripiprazole. Am J Psychiatry 161 (7). 1308
17. Sachs G., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Impellizzeri C., Kaplita S., Rollin L., Iwamoto T. (2006) Aripiprazole Study Group. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacology 20 (4). 536-546
18. Travis M.J., Burns T., Dursun S., Fahy T., Frangou S., Gray R., Haddad P.M., Hunter R., Taylor D.M., Young A.H. (2005) Aripiprazole in schizophrenia: consensus guidelines. Int J Clinical Practice 59 (4). 485-495
19. Vieta E., Bourin M., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Swanink R., Iwamoto T. (2005) on behalf of the Aripoprazole Study Group. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br J Psychiatry 187: 235-242
20. Worthington J.J. 3rd, Kinrys G., Wygant L.E., Pollack M.H. (2005) Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacology 20 (1). 9-11